BioSpace News Archive

The global rheumatology therapeutics market is highly competitive and consolidated due to presence of strong players, finds Transparency Market Research.

The genome engineering market has been anticipated to experience noteworthy growth opportunities in the forthcoming years.

The world bioreactors and fermenters market is characterized with a largely consolidated business landscape and a low to moderate level of market competition, with the top five players holding for a more than around 63% of the said market in 2015, as noted by Transparency Market Research in its recent report.

Echosens, a high-technology company offering the FibroScan® family of products, is pleased to announce its strong presence at the upcoming American Association for the Study of Liver Diseases (AASLD) Liver Meeting, a digital conference, Nov. 12-15, 2021, with FibroScan-based solutions - referenced in 19 oral presentations and 180 poster presentations.

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the third quarter ended September 30, 2021.

Actym Therapeutics, Inc. today announced the appointment of Chan Whiting, Ph.D. as Chief Development Officer.

Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the quarter ended September 30, 2021 with the Securities and Exchange Commission (“SEC”) on Wednesday, November 10, 2021.

Lantern Pharma (NASDAQ: LTRN), today announced that Lantern Pharma’s abstract on the effectiveness of LP-184 in glioblastoma multiforme (GBM) regardless of MGMT status has been accepted as a virtual poster at the upcoming 26th Society for Neuro-Oncology (SNO) Annual Meeting.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Executive Officer Nadav Kidron will present a company overview at the H.C. Wainwright 7th Annual Israel Virtual Conference.

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced activities at the upcoming 2021 Radiology Society of North America (RSNA) Annual Meeting, being held virtually and on-site at McCormick Place in Chicago from Nov. 28 – Dec. 2.